First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.
للمزيد من التفاصيل: إضغط هنا